BioCentury
ARTICLE | Company News

DiaGenic diagnostic news

November 4, 2013 8:00 AM UTC

Diagnostic company DiaGenic received a request from shareholders Corona Maritime A/S and Tycoon Industrier A/S to convene an extraordinary general meeting to address the composition of the board. DiaGenic did not disclose details regarding the request. The meeting must be held no later than Nov. 22. DiaGenic said a formal notice of the meeting will be distributed with a statutory notice period of three weeks and that the meeting will be held within one month of Oct. 23. Corona holds a 4.9% stake, while Tycoon holds a 1.47% stake.

Later in October, the company said it would restructure or seek to divest all of the company's assets. The company said it initiated headcount reductions, but that work to finalize ongoing projects and third-party collaborations would continue during the next three months. The company said in September it would intensify its efforts to obtain equity financing or facilitate an asset or trade sale, but that currently a solution was not yet in place (see BioCentury, Sept. 2). ...